|
Video: What is a Stock Split?
|
|
Alaunos Therapeutics is an oncology-focused cell therapy company developing adoptive T-cell receptor (TCR) therapies, designed to treat various solid tumor types in cancer patient. Co. is utilizing its cancer mutation hotspot TCR library and its proprietary, non-viral Sleeping Beauty genetic engineering technology to design and manufacture patient-specific cell therapies that target neoantigens arising from tumor-related mutations in main oncogenic genes, including KRAS, TP53 and EGFR. Co. evaluates TCRs reactive to mutated KRAS, TP53 and EGFR from its TCR library for the investigational treatment of non-small cell lung, colorectal, endometrial, pancreatic, ovarian and bile duct cancers. According to our Alaunos Therapeutics stock split history records, Alaunos Therapeutics has had 1 split. | |
|
Alaunos Therapeutics (TCRT) has 1 split in our Alaunos Therapeutics stock split history database. The split for TCRT took place on February 01, 2024. This was a 1 for 15 reverse split, meaning for each 15 shares of TCRT owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 66.6666666666667 share position following the split.
When a company such as Alaunos Therapeutics conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Alaunos Therapeutics stock split history from start to finish, an original position size of 1000 shares would have turned into 66.6666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Alaunos Therapeutics shares, starting with a $10,000 purchase of TCRT, presented on a split-history-adjusted basis factoring in the complete Alaunos Therapeutics stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/31/2014 |
|
End date: |
03/27/2024 |
|
Start price/share: |
$68.70 |
|
End price/share: |
$1.86 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-97.29% |
|
Average Annual Total Return: |
-30.30% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$270.87 |
|
Years: |
10.00 |
|
|
|
Date |
Ratio |
02/01/2024 | 1 for 15 |
|
|